Assessing omega-3 fatty acid supplementation during pregnancy and lactation to optimize maternal mental health and childhood cognitive development

References

• Gomez Candela C, Bermejo Lopez LM, Loria Kohen V. Importance of a balanced omega 6/ omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr.Hosp. 26(2), 323–329 (2011).
   Google Scholar
• Adams P, Lawson S, Sanigorski A, Sinclair A. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31, S157–S161 (1996).
   Google Scholar
• Haggarty P. Fatty acid supply to the human fetus. Annu.Rev.Nutr. 30, 237–255 (2010).
   Google Scholar
• Otto S, de Groot R, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. ProstaglandinsLeukot.Essent. FattyAcids 69, 237–243 (2003).
   Google Scholar
• Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Stoll AL. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J.Clin.Psychiatry 67(12), 1954–1967 (2006).
   Google Scholar
• Dziechciarz P, Horvath A, Szajewska H. Effects of n-3 long-chain polyunsaturated fatty acid supplementation during pregnancy and/or lactation on neurodevelopment and visual function in children: a systematic review of randomized controlled trials.J.Am. Coll.Nutr. 29(5), 443–454 (2010).▪ Presents a comprehensive summary of trials concerning maternal long-chain polyunsaturated fatty acid supplementation during pregnancy and lactation.
   Google Scholar
• Davis-Bruno K, Tassinari MS. Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature. BirthDefects Res.BDev.Reprod.Toxicol. 92(3), 240–250 (2011).▪ Summarizes the effects of maternal omega-3 fatty acid supplementation on CNS development in the animal literature, including both the benefits and harms.
   Google Scholar
• Kremmyda LS, Vlachava M, Noakes PS, Diaper ND, Miles EA, Calder PC. Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin. Rev.AllergyImmunol. 41(1), 36–66 (2011).
   Google Scholar
• Schuchardt JP, Huss M, Stauss-Grabo M, Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur. J.Pediatr. 169, 149–164 (2010).
   Google Scholar
• Koletzko B, Lien E, Agostoni Cetal. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J.Perinat.Med. 36(1), 5–14 (2008).
   Google Scholar
• Lumia M, Luukkainen P, Tapanainen Hetal. Dietary fatty acid composition during pregnancy and the risk of asthma in the offspring.Pediatr.AllergyImmunol. 22(8), 827–835 (2011).
   Google Scholar
• Mozaffarian D, Wu JHY. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.J.Am.Coll.Cardiol. 58(20), 2047–2067 (2011).
   Google Scholar
• Shaikh SR, Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation.Am.J.Clin.Nutr. 84(6), 1277–1289 (2006).
   Google Scholar
• Hibbeln JR, Davis JM, Steer Cetal. Maternal seafood consumption in pregnancy and ▪ Observational study suggesting that current US FDA recommendations for limitation of dietary fish intake during gestation may do more harm than good.neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet369(9561), 578–585 (2007).
   Google Scholar
• McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. ProstaglandinsLeukot. Essent.FattyAcids 75(4–5), 329–349 (2006).
   Google Scholar
• Zhang C, Bazan NG. Lipid-mediated cell signaling protects against injury and neurodegeneration. J.Nutr. 140(4), 858–863 (2010).
   Google Scholar
• Ramakrishnan U. Fatty acid status and maternal mental health. Matern.ChildNutr. 7(Suppl. 2), 99–111 (2011).
   Google Scholar
• Grintal B, Champeil-Potokar G, Lavialle M, Vancassel S, Breton S, Denis I. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid. Neurochem.Int. 54(8), 535 (2009).
   Google Scholar
• Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot.Essent.FattyAcids 75(4–5), 259–269 (2006).
   Google Scholar
• Levant B, Ozias M, Carlson S. Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. J.Nutr. 137(1), 130–134 (2007).
   Google Scholar
• Levant B, Ozias M, Davis Petal. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats. Psychoneuroendocrinology 33(9), 1279–1292 (2008).
   Google Scholar
• Davis PF, Ozias MK, Carlson SEetal. Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status. Nutr.Neurosci. 13(4), 161–169 (2010).
   Google Scholar
• Kim H. Novel metabolism of docosahexaenoic acid in neural cells. J.Biol. Chem. 282(26), 18661–18665 (2007).
   Google Scholar
• Bazan NG. Omega-3 fatty acids, proinflammatory signaling and neuroprotection. Curr.Opin.Clin.Nutr.Metab.Care 10(2), 136–141 (2007).
   Google Scholar
• Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat.J.Neurochem. 101(3), 577–599 (2007).
   Google Scholar
• Farooqui AA. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders. Neuroscientist 15(4), 392–407 (2009).
   Google Scholar
• Lotrich FE, El-Gabalawy H, Guenther LC, Ware CF. The role of inflammation in the pathophysiology of depression: different treatments and their effects. J.Rheumatol. Suppl. 88, 48–54 (2011).
   Google Scholar
• Schiepers O, Wichers M, Maes M. Cytokines and major depression.Prog. Neuropsychopharmacol.Biol.Psychiatry 29, 201–217 (2005).
   Google Scholar
• Maes M, Yirmyia R, Noraberg Jetal. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab.BrainDis. 24(1), 27–53 (2009).
   Google Scholar
• Corwin EJ, Johnston N, Pugh L. Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the first month postpartum.Biol.Res.Nurs. 10(2), 128–133 (2008).
   Google Scholar
• Corwin EJ, Pajer K. The psychoneuroimmunology of postpartum depression. J.WomensHealth 17(9), 1529–1534 (2008).
   Google Scholar
• Maes M, Lin A, Ombelet W et al. Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms. Psychoneuroendocrinology 25, 121–137 (2000).
   Google Scholar
• Ferrucci L, Cherubini A, Bandinelli S et al.Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 91(2), 439–446 (2006).
   Google Scholar
• Kawashima A, Harada T, Kami H, Yano T, Imada K, Mizuguchi K. Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells. J.Nutr.Biochem. 21(4), 268–277 (2010).
   Google Scholar
• Moore SA, Yoder E, Murphy S, Dutton GR, Spector AA. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J.Neurochem. 56(2), 518–524 (1991).
   Google Scholar
• Bhattacharya A, Sun D, Rahman M, Fernandes G. Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice. J.Nutr.Biochem. 18(1), 23–30 (2007).
   Google Scholar
• Weldon SM, Mullen AC, Loscher CE, Hurley LA, Roche HM. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J.Nutr.Biochem. 18(4), 250–258 (2007).
   Google Scholar
• Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem. Rev. 111(10), 5922–5943 (2011).
   Google Scholar
• Xu Z, Zhang L, Liu Tetal. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat.Med. 16(5), 592–597 (2010).
   Google Scholar
• Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet.Gynecol. 106(5 Pt 1), 1071–1083 (2005).
   Google Scholar
• Hibbeln J. Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis.J.Affect.Disord. 69, 15–29 (2002).
   Google Scholar
• Golding J, Steer C, Emmett P, Davis JM, Hibbeln JR. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish.Epidemiology 20(4), 598–603 (2009).
   Google Scholar
• Jans LA, Giltay EJ, Van der Does AJ. The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression. Br.J.Nutr. 104(11), 1577–1585 (2010).▪Summarizes the current evidence surrounding maternal omega-3 fatty acid
   Google Scholar
• Makrides M, Gibson RA, McPhee AJ et al.Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children:a randomized controlled trial. JAMA 304(15),1675–1683 (2010).nn Large multicenter, randomized controlledtrial providing the most reliable evidenceconcerning the lack of benefits for maternaldocosahexaenoic acid (DHA)supplementation for prevention of perinataldepressive symptoms and optimization ofchild development.
   Google Scholar
• Llorente A, Jensen C, Voigt R, Fraley J, Berretta M, Heird W. Effect of maternal docasahexaenoic acid supplementation on postpartum depression and information processing. Am.J.Obstet.Gynecol. 188, 1348–1353 (2003).
   Google Scholar
• Krauss-Etschmann S, Shadid R, Campoy C etal. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am.J.Clin.Nutr. 85(5), 1392–1400 (2007).
   Google Scholar
• Rees AM, Austin MP, Parker GB. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust.NZJ.Psychiatry 42(3), 199–205 (2008).
   Google Scholar
• Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study.J.Affect.Disord. 110(1–2), 142–148 (2008).
   Google Scholar
• Su KP, Huang SY, Chiu THetal. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J.Clin. Psychiatry 69(4), 644–651 (2008).
   Google Scholar
• Mattes E, McCarthy S, Gong Getal. Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. BrainBehav.Immun. 23(3), 380–388 (2009).
   Google Scholar
• Doornbos B, van Goor SA, Dijck-Brouwer DA, Schaafsma A, Korf J, Muskiet FA. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog.Neuropsychopharmacol. Biol.Psychiatry 33(1), 49–52 (2009).
   Google Scholar
• Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness:which disorder and which fatty acid? Lipids HealthDis. 6, 21 (2007).
   Google Scholar
• Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J.Am.Coll.Nutr. 28(5), 525–542 (2009).
   Google Scholar
• Mozurkewich E, Chilimigras J, Klemens C etal. The mothers, omega-3 and mental health study. BMCPregnancyChildbirth 11, 46 (2011).
   Google Scholar
• Purvis JM, Clandinin MT, Hacker RR. Fatty acid accretion during perinatal brain growth in the pig. A model for fatty acid accretion in human brain. Comp.Biochem.Physiol.B 72(2), 195–199 (1982).
   Google Scholar
• Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum.Dev. 4(2), 121–129 (1980).
   Google Scholar
• Coti Bertrand P, O’Kusky JR, Innis SM. Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J.Nutr. 136(6), 1570–1575 (2006).
   Google Scholar
• Jorgensen MH, Nielsen PK, Michaelsen KF, Lund P, Lauritzen L. The composition of polyunsaturated fatty acids in erythrocytes of lactating mothers and their infants.Matern. ChildNutr. 2(1), 29–39 (2006).
   Google Scholar
• Cao D, Kevala K, Kim Jetal. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J.Neurochem. 111(2), 510–521 (2009).
   Google Scholar
• Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis invitro and invivo. Neuroscience 139(3), 991–997 (2006).
   Google Scholar
• Sinha RA, Khare P, Rai Aetal. Antiapoptotic role of omega-3-fatty acids in developing brain: perinatal hypothyroid rat cerebellum as apoptotic model.Int.J.Dev. Neurosci. 27(4), 377–383 (2009).
   Google Scholar
• Kuperstein F, Eilam R, Yavin E. Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary deficiency. J.Neurochem. 106(2), 662–671 (2008).
   Google Scholar
• Salem JN. Mechanism of action of docosahexaenoic acid in the nervous system. Lipids 36(9), 945–959 (2001).
   Google Scholar
• Yavin E. Versatile roles of docosahexaenoic acid in the prenatal brain: from pro- and anti-oxidant features to regulation of gene expression. ProstaglandinsLeukot.Essent.Fatty Acids 75(3), 203–211 (2006).
   Google Scholar
• Berman DR, Mozurkewich E, Liu Y, Barks J. Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia–ischemia. Am.J.Obstet. Gynecol. 200(3), 305.E1–305.E6 (2009).
   Google Scholar
• Berman D, Liu Y, Barks J, Mozurkewich E. Treatment with docosahexaenoic acid after hypoxia–ischemia improves forepaw placing in a rat model of perinatal hypoxia–ischemia. Am.J.Obstet.Gynecol. 203(4), 385.E1–385.E5 (2010).
   Google Scholar
• Berman D, Liu Y, Barks J, Mozurkewich E. Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia–ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation. Am.J.Obstet.Gynecol. 202(5), 469 E1–E6 (2010).
   Google Scholar
• Lauritzen L, Carlson SE. Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status. Matern. ChildNutr. 7(Suppl. 2), 41–58 (2011).
   Google Scholar
• Koletzko B, Larque E, Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J.Perinat.Med. 35(Suppl. 1), S5–S11 (2007).
   Google Scholar
• Larque E, Krauss-Etschmann S, Campoy C etal. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am.J.Clin.Nutr. 84(4), 853–861 (2006).
   Google Scholar
• Hanebutt FL, Demmelmair H, Schiessl B, Larqué E, Koletzko B. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin.Nutr. 27(5), 685–693 (2008).
   Google Scholar
• Kuipers RS, Luxwolda MF, Janneke Dijck-Brouwer DA, Muskiet FAJ. Intrauterine, postpartum and adult relationships between arachidonic acid (AA) and docosahexaenoic acid (DHA). ProstaglandinsLeukot.Essent.FattyAcids 85(5), 245–252 (2011).
   Google Scholar
• Boucher O, Burden MJ, Muckle Getal. Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age. Am.J.Clin.Nutr. 93(5), 1025–1037 (2011).
   Google Scholar
• Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch.Dis.ChildFetal NeonatalEd. 93(1), F45–F50 (2008).
   Google Scholar
• Helland IG, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age.Pediatrics 111, 39–44 (2003).
   Google Scholar
• Helland IB, Smith L, Blomen B, Saarem K, Saugstad OD, Drevon CA. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children’s IQ and body mass index at 7 years of age. Pediatrics 122(2), E472–E479 (2008).
   Google Scholar
• Delgado-Noguera MF, Calvache JA, Bonfill Cosp X. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development. CochraneDatabase Syst.Rev. 12, CD007901 (2010).
   Google Scholar
• Judge MP, Harel O, Lammi-Keefe CJ. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am.J.Clin.Nutr. 85(6), 1572–1577 (2007).
   Google Scholar
• Tofail F, Kabir I, Hamadani JDetal. Supplementation of fish-oil and soy-oil during pregnancy and psychomotor development of infants.J.HealthPopul.Nutr. 24(1), 48–56 (2006).
   Google Scholar
• Jensen CL, Voigt RG, Prager TCetal. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am.J.Clin.Nutr. 82(1), 125–132 (2005).
   Google Scholar
• Lauritzen L, Jorgensen MH, Olsen SF, Straarup EM, Michaelsen KF. Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod.Nutr.Dev. 45(5), 535–547 (2005).
   Google Scholar
• Cheatham CL, Nerhammer AS, Asserhoj M, Michaelsen KF, Lauritzen L. Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids 46(7), 637–645 (2011).
   Google Scholar
• Helland IB, Saugstad OD, Smith Letal. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women.Pediatrics 108(5), E82 (2001).
   Google Scholar
• Escolano-Margarit MV, Ramos R, Beyer J etal. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated.J.Nutr. 141(6), 1216–1223 (2011).▪ Meta-analysis of trials concerning omega-3 fatty acid supplementation suggesting that eicosapentaenoic acid and not DHA is the fatty acid to be used in the treatment of depression.▪ Suggests that DHA transfer to the fetus is biomagnified in circumstances of low maternal DHA supply, and bioattenuated in circumstances of high maternal DHA supply.a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. EarlyHum.Dev. 87(3), 223–230 (2011).
   Google Scholar
• Campoy C, Escolano-Margarit MV, Ramos R etal. Effects of prenatal fish-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6.5 year of age. Am.J.Clin.Nutr. 94(Suppl.), 1880S–1888S (2011).
   Google Scholar
• van Goor SA, Janneke Dijck-Brouwer DA, Erwich JJHM, Schaafsma A, Hadders-Algra M. The influence of supplemental docosahexaenoic and arachidonic acids during pregnancy and lactation on neurodevelopment at eighteen months. ProstaglandinsLeukot.Essent.FattyAcids 84(5–6), 139–146 (2011).
   Google Scholar
• Makrides M, Gibson RA, McPhee AJetal. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial.JAMA 301(2), 175–182 (2009).
   Google Scholar
• Schulzke S, Patole S, Simmer K. Longchain polyunsaturated fatty acid supplementation in preterm infants. CochraneDatabaseSyst. Rev. 2, CD000375 (2011).
   Google Scholar
• Agostoni C, Zuccotti GV, Radaelli Getal. Docosahexaenoic acid supplementation and time at achievement of gross motor milestones in healthy infants: a randomized, prospective, double-blind, placebo-controlled trial. Am.J.Clin.Nutr. 89(1), 64–70 (2009).
   Google Scholar
• Simmer K, Patole SK, Rao SC. Longchain polyunsaturated fatty acid supplementation in infants born at term. CochraneDatabaseSyst. Rev. 12, CD000376 (2011).
   Google Scholar
• Drover JR, Hoffman DR, Castaneda YS etal. Cognitive function in 18-month-old term infants of the DIAMOND study:
   Google Scholar